Northern Trust
STLN

Northern Trust’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Northern Trust’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Buy
558,455
+59,211
+12% +$182K ﹤0.01% 3058
2025
Q4 		$1.78M Buy
499,244
+34,552
+7% +$128K ﹤0.01% 3065
2025
Q3 		$1.62M Buy
464,692
+53,335
+13% +$183K ﹤0.01% 3145
2025
Q2 		$843K Buy
411,357
+334,364
+434% +$836K ﹤0.01% 3470
2025
Q1 		$87.8K Buy
76,993
+12,091
+19% +$9.36K ﹤0.01% 4144
2024
Q4 		$20.1K Hold
64,902
– – ﹤0.01% 4376
2024
Q3 		$21.2K Hold
64,902
– – ﹤0.01% 4331
2024
Q2 		$29.9K Sell
64,902
-94
-0.1% -$80 ﹤0.01% 4288
2024
Q1 		$103K Buy
64,996
+1,053
+2% +$2K ﹤0.01% 4077
2023
Q4 		$130K Buy
63,943
+19,355
+43% +$33.6K ﹤0.01% 4045
2023
Q3 		$62.4K Sell
44,588
-3,522
-7% -$3.65K ﹤0.01% 4120
2023
Q2 		$26.5K Sell
48,110
-214,268
-82% -$113K ﹤0.01% 4350
2023
Q1 		$178K Buy
262,378
+4,983
+2% +$6.36K ﹤0.01% 3905
2022
Q4 		$425K Buy
257,395
+2,046
+0.8% +$5.74K ﹤0.01% 3560
2022
Q3 		$1.18M Buy
255,349
+111,428
+77% +$655K ﹤0.01% 3257
2022
Q2 		$729K Buy
143,921
+125,856
+697% +$917K ﹤0.01% 3422
2022
Q1 		$129K Buy
+18,065
New +$122K ﹤0.01% 4273

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust's STLN Position: Q1 2026 in Review

Northern Trust increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 12% in Q1 2026, buying an estimated $182K and bringing the position to 558,455 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3058.

Northern Trust first reported a position in STLN in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.78M in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Northern Trust held 558,455 shares of Starling Oncology Institute, Inc. Common Stock worth $1.71M as of Q1 2026.
  • Northern Trust bought 59,211 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $182K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3058 holding.
  • Northern Trust first reported a position in Starling Oncology Institute, Inc. Common Stock in Q1 2022 and has held it in 17 quarters since.
  • Northern Trust's Starling Oncology Institute, Inc. Common Stock position peaked at $1.78M in Q4 2025.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.